The animal model market has experienced significant growth over the years, driven by the increasing demand for preclinical testing and research in the pharmaceutical and biotechnology industries. Animal models are essential for studying various diseases, drug efficacy, toxicology, and understanding biological processes.

The globalย animal model marketย was valued at $1,469 million in 2020, and is projected to reach $2,677 million by 2030, registering a CAGR of 6.1% from 2021 to 2030.

Technological Advancements: The animal model market has benefited from advancements in genetic engineering techniques such as CRISPR-Cas9, which enable precise modifications in animal genomes. These advancements have led to the development of genetically modified animal models that closely mimic human diseases.

Ethical Concerns: The use of animals in research has been a subject of ethical debate. Animal welfare concerns and the development of alternative testing methods have led to efforts to reduce and refine the use of animals in experimentation. However, animal models continue to be an integral part of scientific research.

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐š ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‚๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:ย 

https://www.alliedmarketresearch.com/request-sample/6464

Market Drivers:

Preclinical Research and Drug Development: Animal models play a crucial role in preclinical research and drug development. They provide a valuable tool for studying the efficacy, safety, and toxicology of new drugs before they progress to human clinical trials. The need to thoroughly evaluate potential therapeutic candidates drives the demand for animal models.

Disease Understanding and Pathogenesis: Animal models contribute to a deeper understanding of disease mechanisms and pathogenesis. They help researchers study the progression of diseases, identify key molecular pathways, and develop targeted treatments. Animal models allow scientists to mimic human diseases and explore various therapeutic interventions.

Request for Customization โ€“ย https://www.alliedmarketresearch.com/request-for-customization/8311

Market Segmentation:

By Type of Animal:

a. Mice: Mice are the most commonly used animal models due to their genetic similarity to humans, ease of handling, and well-characterized genomes.
b. Rats: Rats are widely used in research, particularly in toxicology studies and certain disease models.
c. Rabbits: Rabbits are used for various applications, including vaccine development, ocular research, and cardiovascular studies.
d. Zebrafish: Zebrafish models are popular for studying developmental biology, genetics, and drug screening.
e. Non-human Primates: Non-human primates, such as monkeys, are utilized in research areas that require a closer resemblance to humans, including neuroscience and infectious diseases.

By Application:

a. Drug Discovery and Development: Animal models are extensively employed in the pharmaceutical industry for testing drug candidates and assessing their efficacy, safety, and toxicity.
b. Disease Research: Animal models play a vital role in studying various diseases, including cancer, cardiovascular disorders, neurological conditions, diabetes, and infectious diseases.
c. Genetic Research: Animal models are used in genetic research to understand gene function, study genetic disorders, and develop gene therapies.
d. Toxicology Testing: Animal models are utilized to evaluate the safety and potential adverse effects of drugs, chemicals, and other substances.
e. Biomedical Research: Animal models contribute to a wide range of biomedical research areas, such as immunology, physiology, behavior, and aging.

Competitive Landscape:

Charles River Laboratories International, Inc.
The Jackson Laboratory
Envigo
Taconic Biosciences, Inc.
Janvier Labs
genOway S.A.
Horizon Discovery Group plc
Crown Bioscience, Inc.
Trans Genic Inc.
Laboratory Corporation of America Holdings (LabCorp)

Procure Complete Report :

https://www.alliedmarketresearch.com/purchase-enquiry/6464

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
Allied Market Research Blog: https://blog.alliedmarketresearch.com

Leave a comment

Your email address will not be published. Required fields are marked *